Your Location:Home >Products >API >501692-44-0

Purity:99%
The present invention relates to compoun...
Provided herein are methods of treating ...
C41H56N4O8S2
1,1-dioxo-3,3-dibutyl-5-phenyl-7-methylthio-8-(N-{(R)-α-[N-((S)-1-carboxypropyl)carbamoyl]-4-hydroxybenzyl})carbamoylmethoxy-2,3,4,5-tetrahydro-1,2,5-benzothiadiazepine
| Conditions | Yield |
|---|---|
|
With
trifluoroacetic acid;
In
dichloromethane;
at 18 - 25 ℃;
for 7h;
Inert atmosphere;
|
0.056 g |
1,1-dioxo-3,3-dibutyl-5-phenyl-7-methylthio-8-carboxymethoxy-2,3,4,5-tetrahydro-1,2,5-benzothiadiazepine
1,1-dioxo-3,3-dibutyl-5-phenyl-7-methylthio-8-(N-{(R)-α-[N-((S)-1-carboxypropyl)carbamoyl]-4-hydroxybenzyl})carbamoylmethoxy-2,3,4,5-tetrahydro-1,2,5-benzothiadiazepine
| Conditions | Yield |
|---|---|
|
Multi-step reaction with 4 steps
1.1: 2,6-dimethylpyridine; O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate / dichloromethane / 5 h / 18 - 25 °C / Inert atmosphere
2.1: trifluoroacetic acid / dichloromethane / 4.5 h / 18 - 25 °C / Inert atmosphere
3.1: 4-methyl-morpholine / N,N-dimethyl-formamide / 0.17 h / 18 - 25 °C / Inert atmosphere
3.2: 1 h / 18 - 25 °C / Inert atmosphere
4.1: trifluoroacetic acid / dichloromethane / 7 h / 18 - 25 °C / Inert atmosphere
With
4-methyl-morpholine; 2,6-dimethylpyridine; O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate; trifluoroacetic acid;
In
dichloromethane; N,N-dimethyl-formamide;
|
1,1-dioxo-3,3-dibutyl-5-phenyl-7-methylthio-8-carboxymethoxy-2,3,4,5-tetrahydro-1,2,5-benzothiadiazepine
1,1-dioxo-3,3-dibutyl-5-phenyl-7-methylthio-8-ethoxycarbonylmethoxy-2,3,4,5-tetrahydro-1,2,5-benzothiadiazepine
C37H49N3O7S2
CAS:114772-54-2
CAS:109-15-9
CAS:7783-50-8
CAS:1609960-31-7